<SEC-DOCUMENT>0001144204-17-053603.txt : 20171023
<SEC-HEADER>0001144204-17-053603.hdr.sgml : 20171023
<ACCEPTANCE-DATETIME>20171023162352
ACCESSION NUMBER:		0001144204-17-053603
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		7
CONFORMED PERIOD OF REPORT:	20171017
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20171023
DATE AS OF CHANGE:		20171023

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Arconic Inc.
		CENTRAL INDEX KEY:			0000004281
		STANDARD INDUSTRIAL CLASSIFICATION:	ROLLING DRAWING & EXTRUDING OF NONFERROUS METALS [3350]
		IRS NUMBER:				250317820
		STATE OF INCORPORATION:			PA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-03610
		FILM NUMBER:		171149173

	BUSINESS ADDRESS:	
		STREET 1:		390 PARK AVENUE
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10022-4608
		BUSINESS PHONE:		2128362732

	MAIL ADDRESS:	
		STREET 1:		390 PARK AVENUE
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10022-4608

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ALCOA INC.
		DATE OF NAME CHANGE:	20141003

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ALCOA INC
		DATE OF NAME CHANGE:	19990105

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ALUMINUM CO OF AMERICA
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>tv477513_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Washington, D. C. 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>FORM 8-K</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>CURRENT
REPORT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Pursuant
to Section&nbsp;13 or 15(</B></FONT><B>d<FONT STYLE="text-transform: uppercase">)&nbsp;of the</FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Securities
Exchange Act of 1934</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Date of Report (Date of earliest event reported):
October 23, 2017 (October 17, 2017)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 24pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="background-color: white"><B>ARCONIC
INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(Exact name of registrant as specified in its
charter)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR>
    <TD STYLE="vertical-align: top; width: 34%; text-align: center"><FONT STYLE="font-size: 10pt"><B>Pennsylvania</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 1%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 32%; text-align: center"><FONT STYLE="font-size: 10pt"><B>1-3610</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 1%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 32%; text-align: center"><FONT STYLE="font-size: 10pt"><B>25-0317820</B></FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt"><B>(State or other Jurisdiction</B></FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt"><B>(Commission File Number)</B></FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt"><B>(IRS Employer</B></FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt"><B>of Incorporation)</B></FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt"><B>Identification No.)</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR>
    <TD STYLE="vertical-align: top; width: 67%; text-align: center"><FONT STYLE="font-size: 10pt"><B>390 Park Avenue, New York, New York</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 1%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 32%; text-align: center"><FONT STYLE="font-size: 10pt"><B>10022-4608</B></FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt"><B>(Address of Principal Executive Offices)</B></FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt"><B>(Zip Code)</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><B>Office of Investor
Relations 212-836-2758</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><B>Office of the Secretary
212-836-2732</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><B>(Registrant&rsquo;s
telephone number, including area code)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><B>(Former Name or
Former Address, if Changed Since Last Report)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Check the appropriate box below if the Form&nbsp;8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.4in; text-align: left"><FONT STYLE="font-family: Wingdings">&uml;</FONT></TD><TD STYLE="text-align: justify">Written communications pursuant to Rule&nbsp;425 under
the Securities Act (17 CFR 230.425)</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.4in; text-align: left"><FONT STYLE="font-family: Wingdings">&uml;</FONT></TD><TD STYLE="text-align: justify">Soliciting material pursuant to Rule&nbsp;14a-12 under
the Exchange Act (17 CFR 240.14a-12)</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.4in; text-align: left"><FONT STYLE="font-family: Wingdings">&uml;</FONT></TD><TD STYLE="text-align: justify">Pre-commencement communications pursuant to Rule&nbsp;14d-2(b)&nbsp;under
the Exchange Act (17 CFR 240.14d-2(b))</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.4in; text-align: left"><FONT STYLE="font-family: Wingdings">&uml;</FONT></TD><TD STYLE="text-align: justify">Pre-commencement communications pursuant to Rule&nbsp;13e-4(c)&nbsp;under
the Exchange Act (17 CFR 240.13e-4(c))</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 30pt; text-indent: -30pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 (&sect;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange
Act of 1934 (&sect;240.12b-2 of this chapter).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 4in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 30%; padding-left: 40pt"><FONT STYLE="font-size: 10pt">Emerging growth company</FONT></TD>
    <TD STYLE="width: 10%"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&uml;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided
pursuant to Section 13(a) of the Exchange Act. <FONT STYLE="font-family: Wingdings">&uml;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: left"><B>Item
5.02. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements
of Certain Officers.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B><I>Appointment of Chief Executive Officer</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">On October 23, 2017, Arconic Inc. (the &ldquo;Company&rdquo;)
announced that the Board of Directors of the Company (the &ldquo;Board&rdquo;) appointed Charles P. &ldquo;Chip&rdquo; Blankenship,
as Chief Executive Officer of the Company, effective January 15, 2018 (the &ldquo;Effective Date&rdquo;), to succeed Interim Chief
Executive Officer David P. Hess. Mr. Hess will continue to serve on the Board as a director. Upon the Effective Date, Mr. Blankenship
will also join the Board as a director. Mr. Blankenship will be appointed to serve on one or more Board committees on or after
the Effective Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Mr. Blankenship, age 51, was Senior Vice President
of Haier Group, and President and Chief Executive Officer of its GE Appliances business from June 2016 to June 2017. He currently
serves as advisor to the Executive Council of GE Appliances. GE Appliances was a division of General Electric Company until June
2016, when it was acquired by Qingdao Haier Co., Ltd., and Mr. Blankenship served as its President and Chief Executive Officer
from December 2011 until June 2016. Prior to GE Appliances, Mr. Blankenship served as Vice President and General Manager of the
Commercial Engines Operation for GE Aviation from July 2008 until December 2011. From April 2006 to July 2008, Mr. Blankenship
was the General Manager of Aero Energy, a division of GE Energy. Mr. Blankenship earned a Bachelor&rsquo;s of Science degree in
materials engineering from Virginia Tech and a doctorate in materials science and engineering from the University of Virginia.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><I>Employment Agreement</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The Company entered into a letter agreement
dated October 19, 2017 with Mr. Blankenship in connection with his appointment as Chief Executive Officer of the Company, effective
as of the Effective Date. Pursuant to the letter agreement, Mr. Blankenship will receive a base salary at an annual rate of $1,250,000,
will be eligible for a target annual cash incentive compensation opportunity of 150% of his salary, and will receive a 2018 annual
equity award with a grant date fair value of $8,500,000. The letter agreement provides that Mr. Blankenship will be paid a special
sign-on cash bonus of $650,000 and will be granted a special one-time stock option award with a grant date fair value of $4,000,000,
vesting in full on the fourth anniversary of the grant date, subject to his continued employment with the Company, as well as a
special one-time restricted stock unit award with a grant date fair value of $3,000,000, vesting in full on the third anniversary
of the grant date, subject to his continued employment with the Company. Pursuant to the letter agreement, Mr. Blankenship has
committed to purchase shares of Arconic common stock with an aggregate purchase price of $1,000,000.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The letter agreement requires Mr. Blankenship
to relocate to the metropolitan area in which the Company headquarters is located within 18 months following the Effective Date,
and provides certain pre-relocation benefits in connection with his performance of services at the Company headquarters, including
use of Company aircraft to commute between his current residence and Company headquarters. The letter agreement also provides that
Mr. Blankenship will be eligible to participate in the Company&rsquo;s Executive Severance Plan and Change in Control Severance
Plan and that, for purposes of his participation in the Executive Severance Plan, a resignation by him for good reason (as defined
in the letter agreement) would constitute a severance event.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Mr. Blankenship also entered into a confidentiality,
developments, non-competition and non-solicitation agreement attached to the letter agreement, which includes a perpetual confidentiality
covenant as well as non-competition and employee and customer non-solicitation covenants that apply during employment and for a
period of one year following termination of employment for any reason.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The foregoing description of the letter agreement
does not purport to be complete and is qualified in its entirety by reference to the full text of the letter agreement filed herewith
as Exhibit 10.1 and incorporated herein by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">In addition, the Company will enter into an
indemnity agreement with Mr. Blankenship, in the form approved in principle by the Company&rsquo;s shareholders and which the Company
has entered into with each of its directors and officers to supplement the indemnification coverage provided by the Company&rsquo;s
Articles of Incorporation and By-Laws and the Pennsylvania Business Corporation Law. (See Form of Indemnity Agreement between the
Company and individual directors or officers, incorporated by reference to exhibit 10(j) to the Company&rsquo;s Annual Report on
Form 10-K (Commission file number 1-3610) for the year ended December 31, 1987.)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">A copy of the Company&rsquo;s press release
announcing the appointments of Mr. Blankenship as Chief Executive Officer and Mr. Plant as Chairman of the Board, described below
in Item 8.01, is attached hereto as Exhibit 99.1 and is incorporated herein by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B><I>&nbsp;</I></B></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B><I>Compensation Arrangements with Interim Chief Executive Officer</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">On October 23, 2017, the Company awarded Mr.
Hess deferred restricted stock units with a grant date value of $3,000,000, which will vest on the Effective Date, subject to his
continued employment through the Effective Date, and will be settled in three equal installments on each of the first three anniversaries
of the Effective Date. The Company also established a target annual bonus opportunity for Mr. Hess for the 2017 fiscal year of
$1,000,000, with the amount of any actual bonus to be determined following the conclusion of the fiscal year, based upon actual
Company performance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B><I>Appointment of Eric V. Roegner and Departure of Karl Tragl</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">On October 17, 2017, Arconic appointed Eric
V. Roegner as Executive Vice President and Group President, Arconic Engineered Products and Solutions, succeeding Karl Tragl, effective
as of October 23, 2017. Mr. Roegner, who joined the Company in 2006, served as Executive Vice President and Group President, Arconic
Global Rolled Products, in his most recent role.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">A copy of the Company&rsquo;s press release
announcing the appointment of Mr. Roegner and the departure of Mr. Tragl is attached hereto as Exhibit 99.2 and is incorporated
herein by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.75in"><B>Item 8.01.</B></TD><TD><B>Other Events.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">On October 23, 2017, the Company announced that
the independent directors of the Board appointed John C. Plant, a current independent director of the Company, as Chairman of the
Board, effective October 23, 2017, to succeed Interim Chair Patricia F. Russo. Ms. Russo will continue to serve on the Board as
a director.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">A copy of the Company&rsquo;s press release
announcing the appointments of Mr. Blankenship as Chief Executive Officer, described above in Item 5.02, and Mr. Plant as Chairman
of the Board, is attached hereto as Exhibit 99.1 and is incorporated herein by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.75in"><B>Item 9.01.</B></TD><TD><B>Financial Statements and Exhibits.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left">(d)</TD><TD STYLE="text-align: justify">Exhibits.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 24.5pt; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR>
    <TD NOWRAP STYLE="vertical-align: bottom; width: 12%; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Exhibit No.</B></FONT></TD>
    <TD NOWRAP STYLE="vertical-align: top; width: 1%; padding-bottom: 1pt">&nbsp;</TD>
    <TD NOWRAP STYLE="vertical-align: bottom; width: 87%; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Description</B></FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><A HREF="tv477513_ex10-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif">10.1</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD><A HREF="tv477513_ex10-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif">Letter agreement, by and between Arconic Inc. and Charles P. Blankenship, dated as of October 19, 2017.</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><A HREF="tv477513_ex99-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif">99.1</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD><A HREF="tv477513_ex99-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif">Arconic Inc. press release, dated October 23, 2017.</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><A HREF="tv477513_ex99-2.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif">99.2</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD><A HREF="tv477513_ex99-2.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif">Arconic Inc.&nbsp;&nbsp;press release, dated October 23, 2017.</FONT></A></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 24.5pt; background-color: white">&nbsp;</P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center; background-color: white"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>SIGNATURE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 27.5pt">Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">ARCONIC INC.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 55%">&nbsp;</TD>
    <TD STYLE="width: 6%">&nbsp;</TD>
    <TD STYLE="width: 39%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Dated:&nbsp;&nbsp; October 23, 2017</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">/s/ Katherine H. Ramundo</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Katherine H. Ramundo</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Executive Vice President, Chief Legal Officer and Secretary</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;</P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center; background-color: white">EXHIBIT
INDEX</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 24.5pt; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR>
    <TD NOWRAP STYLE="vertical-align: bottom; width: 12%; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Exhibit No.</B></FONT></TD>
    <TD NOWRAP STYLE="vertical-align: top; width: 1%; padding-bottom: 1pt">&nbsp;</TD>
    <TD NOWRAP STYLE="vertical-align: bottom; width: 87%; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Description</B></FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><A HREF="tv477513_ex10-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif">10.1</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD><A HREF="tv477513_ex10-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif">Letter agreement, by and between Arconic Inc. and Charles P. Blankenship, dated as of October 19, 2017.</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><A HREF="tv477513_ex99-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif">99.1</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD><A HREF="tv477513_ex99-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif">Arconic Inc. press release, dated October 23, 2017.</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><A HREF="tv477513_ex99-2.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif">99.2</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD><A HREF="tv477513_ex99-2.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif">Arconic Inc. press release, dated October 23, 2017.</FONT></A></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 24.5pt; background-color: white"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;</P>


<!-- Field: Page; Sequence: 5; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>tv477513_ex10-1.htm
<DESCRIPTION>EXHIBIT 10.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">Exhibit 10.1</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 85%; font-size: 10pt"><IMG SRC="tv477513_ex10-1img1.jpg" ALT="">&nbsp;</TD>
    <TD STYLE="width: 15%">
        <P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0">Arconic</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">390 Park Avenue</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">New York, NY 10022</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Patricia F. Russo</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Interim Chair</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Board of Directors</P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">October 19, 2017</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Charles P. Blankenship</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">1005 Anchorage Woods Circle</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Louisville, KY 40223</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Dear Chip:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As we have discussed, on behalf of Arconic Inc. (&ldquo;Arconic&rdquo;
or the &ldquo;Company&rdquo;), I am pleased to offer you the position of Chief Executive Officer, effective January 15, 2018 (the
&ldquo;Effective Date&rdquo;). As Chief Executive Officer you will report directly to the Company&rsquo;s Board of Directors (the
&ldquo;Board&rdquo;). You will also be appointed as a member of the Board effective as of the Effective Date. During your employment
with the Company, you will devote substantially all of your working time and attention to the business and affairs of the Company
(excluding any vacation to which you are entitled) and you&nbsp;will comply with the Company&rsquo;s policies and rules, as in
effect from time to time. Set forth below is your total compensation package, together with other important information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><U>Base Salary</U>:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Your annual salary will initially be $1,250,000, paid on a monthly
basis in accordance with the Company&rsquo;s normal payroll practices, and subject to all applicable taxes and withholdings.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><U>Incentive Compensation</U>:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">You will initially be eligible for a target annual cash incentive
compensation opportunity of 150% of your base salary (i.e., $1,875,000 based on your initial base salary) for a full year, if individual
and business performance targets are met. Actual payouts could be higher or lower than target depending on individual and business
performance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><U>Sign-On Cash Bonus</U>:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">You will receive a special sign-on cash bonus of $650,000, less
applicable tax withholding, payable as soon as administratively feasible after the Effective Date. Should you voluntarily terminate
your employment with Arconic for any reason in the first 12 months after your receipt of the bonus, you agree to reimburse the
Company for the full amount of the bonus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><U>Initial Equity Awards</U>:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">You will receive a special one-time stock option award with a grant
date fair value of $4,000,000, which will vest in full on the fourth anniversary of the grant date, subject to your continued employment
with the Company through such anniversary date. The grant date will be as soon as administratively feasible after the Effective
Date. The exercise price for the stock options will be the closing price of the Company&rsquo;s common stock on the NYSE on the
date of grant. The foregoing award will be subject to the provisions of the Arconic Stock Incentive Plan and the stock option terms
and conditions thereunder at the time of grant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In addition, you will receive a special one-time restricted stock
unit award with a grant date fair value of $3,000,000, which will vest in full on the third anniversary of the grant date, subject
to your continued employment with the Company through such anniversary date. The grant date will be as soon as administratively
feasible after the Effective Date. The foregoing award will be subject to the provisions of the Arconic Stock Incentive Plan and
the restricted stock unit terms and conditions thereunder at the time of grant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><U>Annual Equity Awards</U>:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">You will be eligible for an annual equity compensation award.&nbsp;
As part of the normal grant cycle in January 2018, you will be granted an award with a grant date fair value of $8,500,000, which
will be subject to the provisions of the Arconic Stock Incentive Plan and the applicable terms and conditions thereunder at the
time of grant.&nbsp; Eighty percent (80%) of the award will be granted as performance-based restricted stock units and twenty percent
(20%) of the award will be granted as time-vested stock options. The design of the executive equity compensation award program
is reviewed each year and is subject to change.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><U>Equity Ownership Requirements</U>:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Consistent with Arconic&rsquo;s efforts to align the interests of
its senior leadership with the interests of Arconic shareholders, the Board has adopted equity ownership requirements for senior
Arconic executives. You will be subject to these requirements, currently 6.0 times base salary for the Chief Executive Officer,
during your employment with the Company. Until equity ownership requirements are met, you are required to retain 50% of shares
acquired upon vesting of restricted stock units and performance-based restricted stock units or upon exercise of stock options,
after deducting those used to pay for applicable taxes and/or the exercise price.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><U>Stock Purchase Commitment</U>:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">You hereby agree that, as soon as practicable following the public
announcement of your appointment as Chief Executive Officer and in any event no later than June 30, 2018, you will purchase shares
of Arconic common stock with an aggregate purchase price of $1,000,000. All shares of Arconic common stock so purchased by you
will count towards your equity ownership requirement. You agree not to dispose of any shares of Arconic common stock so purchased
prior to the earlier of (i) the date on which you meet the equity ownership requirement without including the portion of these
shares that you propose to sell and (ii) your termination of employment with Arconic. You further acknowledge and agree that you
are subject to Arconic&rsquo;s policy against hedging and pledging Company stock, as in effect from time to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><U>Expense Reimbursement, Temporary Housing and Related Expenses,
and Permanent Relocation</U>:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">You will be reimbursed for business-related expenses incurred by
you in performing your duties hereunder in accordance with the Company&rsquo;s policies and procedures as in effect from time to
time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Within eighteen (18) months following the Effective Date, you will
relocate and establish a permanent residence in the metropolitan area in which the Company headquarters is then located (the &ldquo;Company
Headquarters Location&rdquo;). During the period (the &ldquo;Relocation Period&rdquo;) commencing on the Effective Date and ending
on the earlier of the date on which you establish a permanent residence in the Company Headquarters Location and the date that
is eighteen (18) months following the Effective Date, you will be reimbursed for reasonable expenses for temporary corporate housing
and reasonable day-to-day living expenses incurred while you are performing services for the Company in the Company Headquarters
Location. To the extent that you are required to recognize any such expense reimbursements as taxable income, the Company will
provide you with an additional make-whole payment intended to place you in the same after-tax position that you would have been
in had you not recognized such amounts as taxable income. Each such make-whole payment will be calculated and paid in accordance
with the Company&rsquo;s customary practices for payments of this type, as in effect from time to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the Relocation Period, the Company will allow you to use
Company aircraft or, in the event that the Company aircraft is unavailable, will reimburse you for the cost of a commercial flight,
for purposes of commuting between Louisville, Kentucky and the Company Headquarters Location, provided that the maximum aggregate
incremental cost to the Company of such aircraft use, as determined by the Company, together with all such reimbursements for commercial
flights, shall not exceed $200,000 in any calendar year or $300,000 in the aggregate. You agree to provide all information reasonably
requested by the Company in order to monitor the incremental cost to the Company of your Company aircraft use and commercial flight
reimbursements. You are responsible for any and all commuting expenses once the aggregate incremental cost to the Company of your
Company aircraft use and commercial flight reimbursements has reached the annual or aggregate limits set forth above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In addition, Arconic provides a Transfer and Relocation Plan, the
terms of which are determined by the Company in its discretion from time to time, to help facilitate your permanent relocation.
Should you voluntarily terminate your employment with Arconic in the first 24 months after you permanently relocate to the Company
Headquarters Location, you agree to reimburse the Company for the cost actually incurred by the Company under the Transfer and
Relocation Plan in respect of your permanent relocation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><U>Benefits</U>:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During your employment with the Company, you will be eligible to
participate in Company benefit plans as in effect from time to time on the terms applicable to Company senior executives generally
(subject to the applicable eligibility and other requirements set forth therein), including health care, life insurance, and disability
coverage. Information regarding these plans is enclosed herewith for your reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><U>Retirement Savings Plan</U>:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Arconic offers a tax qualified 401(k) savings plan and a non-qualified
deferred compensation plan to help you save toward retirement. Information regarding these plans is enclosed herewith for your
reference. Current Company contributions are:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">3% of your base salary and incentive compensation, and</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">a match of your deferred pre-tax savings dollar-for-dollar up to 6%
of your base pay. </FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><U>Vacation</U>:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="background-color: white">During your employment with
the Company, you will be entitled to such vacation benefits as are available to similarly situated Company senior executives from
time to time (but not less than four (4) weeks per year),</FONT> in addition to Company-recognized holidays.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><U>Confidentiality, Developments, Non-Competition
and Non-Solicitation Agreement</U>:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In consideration of your employment with the
Company, you agree to execute the Confidentiality, Developments, Non-Competition and Non-Solicitation Agreement attached hereto
as <U>Annex A</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><U>Severance</U>:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On the Effective Date, you will become an Eligible Employee under
the Arconic Inc. Executive Severance Plan and the Arconic Inc. Change in Control Severance Plan. Your participation in such plans
is subject to the terms and conditions of such plans as in effect from time to time, provided that, for purposes of your participation
in the Executive Severance Plan, your resignation for &ldquo;Good Reason&rdquo; (as defined below) will be treated as a &ldquo;Severance
Event&rdquo; as such term is used in the Executive Severance Plan. Copies of the current plans are enclosed herewith for your reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&ldquo;Good Reason&rdquo; means the occurrence of any of the following
without your consent: (i) elimination of the Chief Executive Officer title or a change in your reporting relationship so that you
no longer report to the Board, (ii) failure by the Company to appoint you as a member of the Board as of the Effective Date, (iii)
failure by the Company to grant the special sign-on cash bonus, special one-time stock option award, special one-time restricted
stock unit award, or 2018 annual equity award, in each case, in accordance with the terms of this letter, or (iv) a material diminution
in your base salary or target annual cash incentive compensation opportunity (other than pursuant to an across-the-board reduction
that applies to Company senior executives generally); provided that, in order for your resignation to constitute a resignation
for Good Reason, (A) you must provide notice to the Company of the existence of the condition described in clauses (i)-(iv) within
30 days after the initial existence of the condition, upon the notice of which the Company has 30 days to remedy the condition,
and (B) if the condition is not remedied by the Company within 30 days after delivery of the notice, you must resign from employment
with the Company within 30 days after the Company&rsquo;s failure to remedy the condition.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><U>Indemnification</U>:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">You will be covered as an insured officer under
the Company&rsquo;s director and officer liability insurance policy, as in effect from time to time, to the same extent, and on
the same terms, as other executive officers of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><U>Section 409A</U>:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The payments and benefits provided under this
letter are intended to comply with, or be exempt from, the requirements of Section 409A of the Internal Revenue Code of 1986, as
amended, and the provisions of this letter shall be interpreted and applied consistently with such intent. All reimbursements under
this letter that constitute deferred compensation within the meaning of Section 409A will be made or provided in accordance with
the requirements of Section 409A, including, without limitation, that (i) in no event will any reimbursement payments be made later
than the end of the calendar year next following the calendar year in which the applicable expenses were incurred; (ii) the amount
of reimbursement payments that the Company is obligated to pay in any given calendar year shall not affect the amount of reimbursement
payments that the Company is obligated to pay in any other calendar year; and (iii) your right to have the Company pay such reimbursements
may not be liquidated or exchanged for any other benefit. All income tax make-whole payments provided under this letter will be
paid no later than the end of your taxable year next following your taxable year in which the taxes are remitted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><U>Miscellaneous</U>:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Your employment with the Company will at all
times be at-will. Subject to your rights to the payments and benefits upon certain termination of employment in accordance with
the terms of the Executive Severance Plan and the Change in Control Severance Plan, in each case, as in effect from time to time,
and this letter, nothing herein will confer upon you any right to continue in the employment of the Company for any period of specific
duration or interfere with or otherwise restrict in any way the rights of the Company or you to terminate your employment at any
time and for any reason, with or without cause. Upon your termination of employment for any reason and as a condition to any payments
and benefits to which you may become entitled under the Executive Severance Plan or Change in Control Severance Plan, at the request
of the Board you will immediately resign from the Board, your position as an officer of the Company and all offices and directorships
of all subsidiaries and affiliates of the Company. Any waiver of any breach of this letter shall not be construed to be a continuing
waiver or consent to any subsequent breach on the part of either you or the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><U>Successors</U>:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Neither party hereto may assign any rights
or delegate any duties under this letter without the prior written consent of the other party; provided, however, that this letter
shall inure to the benefit of and be binding upon the successors and assigns of the Company upon any sale of all or substantially
all of the Company&rsquo;s assets, or upon any merger, consolidation or reorganization of the Company with or into any other corporation,
all as though such successors and assigns of the Company and their respective successors and assigns were the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><U>Entire Agreement</U>:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Except as otherwise contemplated herein, this
letter contains the entire agreement between you and the Company with respect to the subject matter hereof. No modification or
termination of this letter may be made orally, but must be made in writing and signed by you and the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><U>Governing Law; Jurisdiction</U>:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">This letter will be governed and interpreted
in accordance with the laws of the State of New York without reference to its choice of law principles. Any action arising out
of or related to this letter will be brought in the state or federal courts with jurisdiction in New York, New York, and you and
the Company consent to the jurisdiction and venue of such courts.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">This offer is contingent upon the following conditions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">v</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Having successfully completed a pre-employment drug screen. You will
need to present a photo ID at the time of your screening. </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">v</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Providing authorization and release for Arconic to conduct a comprehensive
review of your background, the result of which is satisfactory to Arconic. The authorization and release will also be valid for
subsequent reports during your period of employment with Arconic.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">v</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Providing us with documentation in the original form establishing
both your identity and your employment eligibility in the U.S. </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">v</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Signing the attached Confidentiality, Developments, Non-Competition
and Non-Solicitation Agreement. </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">v</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Your truthful representation that you are not subject or party to
any agreement, understanding or undertaking, including any restrictive covenant with any prior employer, that would prohibit or
restrict you from accepting the position of Chief Executive Officer of the Company or from performing your duties with the Company.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">To accept our offer, please sign and date the bottom of this letter
and return it to me by October 19, 2017. If you have any questions, please feel free to call me.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">I look forward to officially welcoming you to Arconic.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Best Regards,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; border-bottom: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Patricia F. Russo</FONT></TD>
    <TD STYLE="width: 50%; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Patricia F. Russo</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interim Chair</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Arconic Board of Directors</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left">cc:</TD><TD STYLE="text-align: justify">Vas Nair</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><I>Attachments: </I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Confidentiality, Developments, Non-Competition and Non-Solicitation
Agreement</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">I, Charles P. Blankenship, am pleased to accept your offer of employment
dated October 19, 2017, for the position of Chief Executive Officer in the terms detailed in the offer letter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accepted by:</FONT></TD>
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="width: 48%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Charles P. Blankenship</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-decoration: underline"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>October 19, 2017</U></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Charles P. Blankenship</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B><U>Annex A </U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B><U>Confidentiality, Developments, Non-Competition,
and Non-Solicitation Agreement</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">As an employee of Arconic
Inc. (&ldquo;Arconic&rdquo;) or one of its subsidiaries (Arconic collectively with its subsidiaries, the &ldquo;Company&rdquo;),
you (&ldquo;you&rdquo; or &ldquo;Employee&rdquo;) will have access to or may develop confidential and proprietary information (as
defined below) of the Company. Therefore, in consideration of your employment, and recognizing the highly competitive nature of
the Company&rsquo;s business, you enter into this Confidentiality, Non-Competition, and Non-Solicitation Agreement (this &ldquo;Agreement&rdquo;)
intending to be legally bound.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B><U>Confidentiality</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">You acknowledge that, as
an employee of the Company, you have access, and are privy, to information which is confidential and proprietary to the Company
and which is not generally available to the public from sources outside of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">You agree to regard and
preserve as confidential any and all Confidential Information pertaining to the Company&rsquo;s operations and affairs and all
information which is either learned or obtained by you during your employment, and which you know, or have reason to believe, includes
Confidential Information. You agree that you will use Confidential Information only for the performance of your duties for the
Company and you agree not to disclose any Confidential Information you acquire, except as expressly permitted below. You understand
and agree that this obligation of confidentiality shall continue indefinitely following the termination of your employment with
the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Nothing in this Agreement
shall prohibit or restrict you from: (i) making any disclosure of relevant and necessary information or documents in any action,
investigation, or proceeding relating to this Agreement, or as required by law or legal process; or (ii) participating, cooperating,
or testifying in any action, investigation, or proceeding with, or reporting possible violations or providing information to, any
governmental agency or legislative body regarding this Agreement or the Company, including, but not limited to, the Company&rsquo;s
Legal Department, the Securities &amp; Exchange Commission, and/or pursuant to the Dodd-Frank Act (including without limitations
the whistleblower provisions thereof) or Sarbanes-Oxley Act; provided that, other than with respect to providing information to
a governmental agency and to the extent permitted by law, upon receipt of any subpoena, court order or other legal process compelling
the disclosure of any such information or documents, you will give the General Counsel of the Company prompt written notice so
as to permit the Company to protect its interests in confidentiality to the fullest extent possible. Notwithstanding any provision
of this Agreement to the contrary, the provisions of this Agreement are not intended to, and shall be interpreted in a manner that
does not, limit or restrict you from exercising any legally protected whistleblower rights (including pursuant to Rule 21F under
the Securities Exchange Act of 1934, as amended).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Upon termination of your
employment or at any time requested by the Company, you will deliver promptly to the Company all memoranda, notes, records, reports
and other documents (whether in paper or electronic form and all copies thereof) relating to the business of the Company and all
other Company property which you obtained or developed while employed by, or otherwise serving or acting on behalf of, the Company
and which you may then possess or have under your control, whether directly or indirectly.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B><U>Disclosure of Developments and Other
Inventions</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Without disclosing any
third party confidential information, Employee shall promptly disclose to Company all Developments and any inventions or developments
that Employee believes do not constitute a Development, so that Company can make an independent assessment. Employee represents
and warrants that if Employee developed, conceived or created any Development or other Intellectual Property prior to the date
hereof that relates to Company&rsquo;s Business, Employee has listed such Intellectual Property on Appendix 1 in a manner that
does not violate any third party rights or disclose any third party confidential information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B><U>Ownership of Developments</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Ownership</U>: All right,
title and interest (including all Intellectual Property rights of any sort throughout the world) relating to any and all Developments
(other than Employee Statutorily Exempt Developments) shall be the exclusive property of Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Assignment of Rights</U>:
In consideration of Employee&rsquo;s employment by Company as set forth in the Employment Agreement, Employee hereby assigns to
Company or its designee any and all right, title and/or interest (including all Intellectual Property rights of any sort throughout
the world) in and to any Developments that Employee has or may in the future acquire with respect to any Developments, provided
that this section shall not apply to any Employee Statutorily Exempt Developments.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Further Assistance and
Assurances</U>: Employee shall, both during and after his/her employment by Company, at the expense of Company, perform all lawful
acts requested by, or on behalf of, Company to enable Company to obtain, perfect, sustain, and enforce its ownership interest in
any Development(s) in accordance with this Section and to obtain and maintain patents, copyrights and other Intellectual Property
rights for such Development(s) throughout the world.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Attorney-In-Fact</U>:
Employee hereby irrevocably designates and appoints Company as Employee&rsquo;s agent and attorney-in-fact, coupled with an interest
and with full power of substitution, to act for and on Employee&rsquo;s behalf to execute and file any document and to do all other
lawfully permitted acts to further the purposes of this Section with the same legal force and effect as if executed by Employee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Acknowledgement of Employee
Statutorily Exempt Developments</U>: Employee acknowledges and agrees that, by executing this Agreement, nothing in this Agreement
is intended to expand the scope of protection provided to Employee by Sections 2870 through 2872 of the California Labor Code or
any other statute of like effect. Employee agrees to promptly advise the Company in writing of any developments that Employee believes
may qualify under Sections 2870 through 2872 of the California Labor Code or any other statute of like effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Records</U>: Employee
agrees to keep and maintain adequate and current records (in the form of notes, sketches, drawings, and in any other form that
may be required by the Company) of all Developments made, written, conceived and/or reduced to practice by Employee during the
period of employment by Company, which records shall be available to and remain the sole property of the Company at all times.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Employee IP &ndash;
Ownership and Restrictions; License</U>: Any discovery, invention, improvement, computer program and related documentation or other
work that (i) is created during the term of Employee&rsquo;s employment with the Company and does not fall within the definition
of the term &ldquo;Development&rdquo; as defined herein, (ii) is an Employee Statutorily Exempt Development, or (iii) was developed,
created, or conceived prior to Employee&rsquo;s employment with Company shall, as between Company and Employee, belong to Employee
and shall not be used by Employee in his or her performance on behalf of the Company. Without limiting Company&rsquo;s other rights
and remedies, if, when acting within the scope of Employee&rsquo;s employment or otherwise on behalf of Company, Employee uses
or discloses Employee&rsquo;s own or any third party&rsquo;s confidential information or other Intellectual Property in violation
of this Agreement (or if any Development cannot be fully made, used, reproduced, distributed and otherwise exploited without using
or violating the foregoing), Employee hereby: (a) grants to Company a perpetual, irrevocable, worldwide, fully-paid, royalty-free,
non-exclusive, sub-licensable right and license to use, exploit and exercise all such confidential information and/or Intellectual
Property rights; and (b) warrants that he/she is entitled to grant such license to the extent the confidential information or Intellectual
Property used by Employee in violation of this Section belongs to a third party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B><U>Restrictive Covenants</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Non-Competition</U>:
During your employment and for a period of one year thereafter (regardless of whether the termination of your employment is voluntary
or involuntary), you will not directly or indirectly (i) engage in, carry on, or provide services (paid or unpaid) whether as a
director, officer, partner, owner, employee, inventor, consultant, advisor, or agent, to any Competitive Business (as defined below)
or (ii) hold any economic interest in any Competitive Business. However, notwithstanding the foregoing, you may own up to five
percent (5%) of the outstanding securities of any publicly traded company and you shall not be prohibited from becoming employed
by, or associated with, a private equity firm or hedge fund (or one of their portfolio companies) that has an investment in a Competitive
Business as long as you have no involvement whatsoever with such Competitive Business (including the formation, planning, or acquisition
of, or investment in, any such Competitive Business).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">It is not the Company&rsquo;s
intention to restrict or limit your activities following your termination of employment with the Company unless it is believed
that there is a substantial possibility that your future services or activities in any of the lines of business in which the Company
is engaged may be detrimental to the Company. So as to not unduly restrict your future employment, if you desire to enter into
any employment arrangement or relationship with any potential Competitive Business within the one-year restricted period, please
consult with the Executive Vice President of Human Resources of Arconic to discuss your intended relationship with the entity.
Due to the many different businesses in which the Company presently engages, or which in the future the Company may engage, we
will discuss your desire to enter into a business or professional relationship with any manufacturer or firm which is a Competitive
Business. The Company&rsquo;s consent will not be unreasonably withheld.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Also, as a reminder, Arconic
stock incentive awards continue to be subject to forfeiture, under the terms of that program, to the extent you become associated
with, employed by, render services to, or own any interest in any business that is in competition with the Company or if you engage
in willful conduct that is injurious to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Non-Solicitation</U>:
During your employment and for a period of one year thereafter (regardless of whether the termination of your employment was voluntary
or involuntary), you will not directly or indirectly (i) solicit, induce or attempt to solicit or induce any employee of the Company
to leave the Company for any reason; (ii) hire or attempt to hire any employee of the Company; or (iii) solicit business from,
or engage in business with, any customer or supplier of the Company that you met and/or dealt with during your employment with
the Company for any purpose. In the event that you become aware that any employee of the Company has been hired by any business
or firm with which you are then affiliated, you will immediately notify the Executive Vice President of Human Resources of Arconic
to confirm your non-solicitation of said employee</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">You acknowledge and agree
that given the nature of the Company&rsquo;s business, which is conducted throughout the world, the unique and extraordinary services
you will be providing to the Company and your position of confidence and trust with the Company, the scope and duration of the
covenants included in this Agreement (the &ldquo;Restrictive Covenants&rdquo;) are reasonable and necessary to protect the legitimate
business interests of the Company. You further acknowledge that you have received substantial consideration from the Company and
that your general skills and abilities are such that you can be gainfully employed in noncompetitive employment, and that this
Agreement will in no way prevent you from earning a living following your employment with the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">You also recognize and
agree that any breach or threatened or anticipated breach of any part of these Restrictive Covenants will result in irreparable
harm to the Company, and that the remedy at law for any such breach or threatened breach will be inadequate. Accordingly, in addition
to any other legal or equitable remedies that may be available to the Company, you agree that the Company will be entitled to obtain
an injunction, without posting a bond, to prevent any breach or threatened breach of any part of these Restrictive Covenants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In the event that any court
of competent jurisdiction finds that the limitations set forth in these Restrictive Covenants are overly broad with respect to
duration, geographic scope or scope of prohibited activities, such court will have the authority to reduce the duration, area or
activities of such provisions so as to be enforceable to the maximum extent compatible with applicable law, and such provisions
will then be enforced as modified.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B><U>Notice of Immunity &ndash; Defend <FONT STYLE="background-color: white">Trade
Secrets Act of 2016</FONT></U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Company employees, contractors,
and consultants may disclose Trade Secrets in confidence, either directly or indirectly, to a Federal, State, or local government
official, or to an attorney, solely for the purpose of reporting or investigating a suspected violation of law, or in a complaint
or other document filed in a lawsuit or other proceeding, if such filing is made under seal. Additionally, Company employees, contractors,
and consultants who file retaliation lawsuits for reporting a suspected violation of law may disclose related Trade Secrets to
their attorney and use them in related court proceedings, as long as the individual files documents containing the Trade Secret
under seal and does not otherwise disclose the Trade Secret except pursuant to court order.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: -0.25in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: -0.25in"><B><U>Definitions
for Purposes of this Agreement</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&ldquo;Business&rdquo;
means areas of actual or demonstrably anticipated research and development conducted (or to be conducted) by, or for the benefit
of, Company as well as all products or services sold by, on behalf of, or for the benefit of Company worldwide.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&ldquo;Competitive Business&rdquo;
means any domestic or international business or firm (including any business in the process of being formed or planned) that is
engaged, or has active plans to become engaged, in any line of business of the Company with which you have had direct functional
accountability, or for which you provided leadership or support, during your last eighteen (18) months of employment with the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&ldquo;Confidential Information&rdquo;
includes, but is not limited to strategic plans, trade secrets, inventions, discoveries, technical and operating know-how, accounting
information, product information, marketing and sales data, business strategies, customer information, and employee data of the
Company that is proprietary in nature, and any similar information, data or materials of third parties that the Company has a duty
to keep confidential</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in">&nbsp;</P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&ldquo;Developments&rdquo;
means all discoveries, inventions, innovations, improvements, computer programs and related documentation, and other works of authorship,
mask works, designs, know-how, ideas and information made, written, conceived and/or reduced to practice, in whole or in part,
(whether or not patentable or subject to other forms of protection) by Employee, individually or with any other person, during
and after the period of Employee&rsquo;s employment by Company that: (a) relate in any manner to the Business or activities of
Company; and/or (b) are created: (i) at any time using Company resources, including, but not limited to, Company computers, cellphones,
smartphones, etc.; (ii) during working hours; (iii) at a Company facility; (iv) by, or on behalf of, Company; and/or (v) using
Confidential Information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&ldquo;Employee Statutorily
Exempt Developments&rdquo; means any Developments which qualify fully under the provisions of any applicable statute (including,
e.g., Section 2870 of the California Labor Code) that prohibits the assignment to Company of Employee&rsquo;s rights in any inventions
developed entirely on Employee&rsquo;s own time without using the Company&rsquo;s equipment, supplies, facilities, resources, trade
secrets or Confidential Information (i.e., excluding inventions that either (i) relate at the time of conception or reduction to
practice of the invention to the Company&rsquo;s Business, or actual or demonstrably anticipated research or development; or (ii)
result from any work performed by Employee for the Company).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&ldquo;Intellectual Property&rdquo;
means any intellectual and industrial property and all rights thereof, including, but not limited to, patents, utility models,
semi-conductor topography rights; copyrights, mask works, authors&rsquo; rights, registered and unregistered trademarks, brands,
domain names, trade secrets, know-how and other rights in information, drawings, logos, plans, database rights, technical notes,
prototypes, processes, methods, algorithms, any technical-related documentation, any software, registered designs and other designs,
in each case, whether registered or unregistered and including applications for registration, and all rights or forms of protection
having equivalent or similar effect anywhere in the world.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B><U>Governing Law; Jurisdiction</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">This Agreement will be
governed and interpreted in accordance with the laws of the State of New York without reference to its choice of law principles.
Any action arising out of or related to this Agreement will be brought in the state or Federal courts located in New York, and
you and the Company consent to the jurisdiction and venue of such courts.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B><U>Amendment; Waiver</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">No provision of this Agreement
may be modified, waived, or discharged unless such waiver, modification or discharge is in writing. Any failure by you or the Company
to enforce any of the provisions of this Agreement should not be construed to be a waiver of such provisions or any right to enforce
each and every provision in the future. A waiver of any breach of this Agreement will not be construed as a waiver of any other
or subsequent breach.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B><U>Successors; Binding Agreement</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company has the right
to assign its rights and obligations under this Agreement to any entity that acquires all or substantially all of the assets of
the business for which you work, and continues your employment. The rights and obligations of the Company under this Agreement
will inure to the benefit and be binding upon the successors and assigns of the Company</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B><U>Severability</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In the event that any one
or more of the provisions of this Agreement is held to be invalid, illegal or unenforceable, the validity, legality and enforceability
of the remainder of this Agreement will not in any way be affected or impaired thereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">This Agreement is the entire
agreement between the parties with respect to the matters covered by this Agreement and it replaces all previous agreements, oral
or written, between the parties regarding such matters. PROVISIONS OF THIS AGREEMENT MAY NOT BE WAIVED OR CHANGED EXCEPT BY A SUBSEQUENT
AGREEMENT SIGNED BY YOU AND AN OFFICER OF THE COMPANY.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">If you agree to the terms
of this Agreement, please sign on the line provided below and return two signed copies. A fully executed copy will be returned
to you for your files after it is signed by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Sincerely,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>ARCONIC INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%; font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By: &nbsp;</FONT></TD>
    <TD STYLE="width: 45%; border-bottom: Black 1pt solid; font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Katherine Hargrove Ramundo</FONT></TD>
    <TD STYLE="width: 50%; font-size: 10pt; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Katherine Hargrove Ramundo</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">AGREED TO AND ACCEPTED AS OF THIS 19th DAY
OF October, 2017:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; border-bottom: Black 1pt solid; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Charles P. Blankenship</FONT></TD>
    <TD STYLE="width: 50%; font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Charles P. Blankenship</FONT></TD>
    <TD>&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Appendix 1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Prior Employee Inventions </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 13; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>tv477513_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>Exhibit 99.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><IMG SRC="tv477513_ex99-1img1.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 54%"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Investor Contact:</B></FONT></TD>
    <TD STYLE="width: 46%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Media Contact:</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Patricia Figueroa</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">Shona Sabnis </FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">(212) 836-2758</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(212) 836-2626</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Patricia.Figueroa@arconic.com</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">Shona.Sabnis@arconic.com</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-size: 12pt"><B>Arconic Appoints
Charles &ldquo;Chip&rdquo; Blankenship Chief Executive Officer </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-size: 12pt"><B>John Plant
Named Chair of the Board</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="background-color: white"><B>New
York, October 23, 2017</B> &ndash; Arconic Inc. (NYSE: ARNC) announced today that its Board of Directors has appointed Charles
&ldquo;Chip&rdquo; Blankenship as Chief Executive Officer and a member of the Arconic Board of Directors, effective January 15,
2018. Mr. Blankenship is a 24-year veteran of General Electric (GE) who spent much of his career in its aviation and jet engine
businesses, including running its commercial engine operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">Blankenship, 51, brings 20 years of aerospace
experience to Arconic, having worked across GE&rsquo;s aviation businesses, including aero engines, industrial gas turbines and
aerospace alloy development. Blankenship previously led GE Aviation&rsquo;s Commercial Engines Operation, the world&rsquo;s leading
producer of large and small jet engines for commercial aircraft.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">A metallurgist by training, Blankenship
began his career with GE in 1992 after earning a B.S. in Materials Engineering from Virginia Tech and a Ph.D. in Materials Science
and Engineering from the University of Virginia. Blankenship&rsquo;s GE career culminated in his appointment as President and Chief
Executive Officer of GE Appliances in December 2011, where he led a significant turnaround of the business and its subsequent 2016
sale to Haier Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">Blankenship is a member of the National
Academy of Engineering and serves on the board of the National Association of Manufacturing (NAM), where he has also led NAM&rsquo;s
Task Force on Competitiveness &amp; the Workforce. He holds seven patents related to jet engine technology.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Chip Blankenship said, &ldquo;Arconic is a company with significant
strengths and tremendous potential. &nbsp;I am eager to engage with customers, employees and the Board to develop plans that capitalize
on our strengths, and deliver outstanding returns for our shareholders. &nbsp;I am excited to join the team and get started.&quot;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="background-color: white">Ms.
Russo said, &ldquo;After a thoughtful and deliberate search, the Board is unanimous that Chip Blankenship is the right leader to
take the helm at Arconic. Chip is an exceptional executive with deep operating experience in aerospace and materials science. He
has a strong </FONT>customer orientation and impressive leadership skills. <FONT STYLE="background-color: white">We are confident
that Chip will lead Arconic to create sustainable and increasing value for customers and for shareholders.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="background-color: white">David
Hess, who has served as Arconic&rsquo;s Interim CEO since April 2017, will remain CEO until the start of Blankenship&rsquo;s tenure
and will continue to serve on the Board after the transition. Interim CEO Hess said, &ldquo;I have known Chip Blankenship for many
years as a colleague and competitor in the aerospace industry and I can personally attest that he is an excellent fit for Arconic.
I couldn&rsquo;t be happier with the Board&rsquo;s selection. I&rsquo;m looking forward to working with him to ensure a seamless
transition and continuing my service as a director to help realize the vast potential of Arconic.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="background-color: white">Acknowledging
Hess&rsquo;s service as Interim CEO, Ms. Russo said, &ldquo;The Board extends its sincere appreciation to David Hess for leading
Arconic during its transition to a permanent CEO. We look forward to David&rsquo;s continued service as a director.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="background-color: white">John
Plant, an Arconic director since 2016, has been appointed Chair of the Board effective immediately. He succeeds Pat Russo, who
stepped into the role on an interim basis in April 2017; Ms. Russo will continue her service on the Board and chair the Governance
committee. Mr.</FONT> Plant, 64, has had a distinguished career in the automotive industry spanning nearly 40 years. He previously
served as Chairman of the Board, President and Chief Executive Officer of TRW Automotive, which was acquired by ZF Friedrichshafen
AG in May 2015.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">Chair Plant said, &ldquo;<FONT STYLE="background-color: white">As
Arconic approaches its first anniversary as a standalone public company it has much to look forward to; </FONT>together with the
entire Board, I look forward to working with Chip to drive Arconic&rsquo;s success into the future.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>About Arconic </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Arconic (NYSE: ARNC) creates breakthrough products that shape industries.
Working in close partnership with our customers, we solve complex engineering challenges to transform the way we fly, drive, build
and power. Through the ingenuity of our people and cutting-edge advanced manufacturing techniques, we deliver these products at
a quality and efficiency that ensure customer success and shareholder value. For more information: <U>www.arconic.com</U>. Follow
@arconic: <U>Twitter</U>, <U>Instagram</U>, <U>Facebook</U>, <U>LinkedIn</U> and <U>YouTube</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><B>Dissemination of Company Information</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Arconic intends to make future announcements regarding Company developments
and financial performance through its website on&nbsp;<U>www.arconic.com</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>



<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>4
<FILENAME>tv477513_ex99-2.htm
<DESCRIPTION>EXHIBIT 99.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>Exhibit 99.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><IMG SRC="tv477513_ex99-2img1.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 54%"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Investor Contact:</B></FONT></TD>
    <TD STYLE="width: 46%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Media Contact:</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Patricia Figueroa</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">Shona Sabnis </FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">(212) 836-2758</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(212) 836-2626</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Patricia.Figueroa@arconic.com</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">Shona.Sabnis@arconic.com</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-size: 12pt"><B>Arconic <FONT STYLE="background-color: white">Announces
Business Leadership Changes </FONT></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-size: 12pt"><B><I>Eric Roegner
appointed head of Engineered Products &amp; Solutions</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-size: 12pt; background-color: white"><B><I>Tim
Myers to lead Global Rolled Products and Transportation &amp; Construction Solutions</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="background-color: white"><B>New
York, October 23, 2017</B> &ndash; Arconic Inc. (NYSE: ARNC) today announced business management changes to streamline and strengthen
its operational executive leadership. The changes are effective immediately.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: #FEFEFE">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: #FEFEFE">Eric Roegner is appointed Executive Vice
President and Group President, Engineered Products and Solutions. He succeeds Karl Tragl who will leave the company. Roegner joined
Alcoa Inc. in 2006 and has 11 years of experience in aerospace and defense. Since his appointment in May 2017 as Executive Vice
President and Group President, Global Rolled Products, Roegner has significantly rationalized and strengthened the business with
overhead reductions expected to save $15 million in 2018. Roegner was previously Chief Operating Officer of Engineered Products
and Solutions where he led the successful integration of the RTI acquisition and oversaw Arconic&rsquo;s jet engine business. He
is co-inventor of the Ampliforge&trade; process, a hybrid technique that combines additive and advanced manufacturing processes.
Roegner holds a bachelor's degree in mechanical and aerospace engineering from Princeton University and an MBA from Case Western
Reserve University. He currently serves on the Board of Governors of the Aerospace Industries Association.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: #FEFEFE">Tim Myers is appointed Executive Vice
President and Group President, Global Rolled Products (GRP) and Transportation &amp; Construction Solutions (TCS). Myers joined
Alcoa in 1992 as an automotive applications engineer and has a strong background in automotive and commercial transportation. He
was appointed Executive Vice President and Group President, Transportation and Construction Solutions in May 2016 and led the Group
to achieve five consecutive quarters of year on year EBITDA growth through June 2017. Myers was previously President of Alcoa Wheel
and Transportation Products (AWTP) where he drove the business to increase innovation, profitably grow market share and expand
internationally. Myers has also held automotive engineering and commercial roles for Global Rolled Products and Alcoa Forged Products.
Prior to joining Alcoa, he was a product design engineer for Ford Motor Company. Myers holds a Bachelor&rsquo;s of Science in&nbsp;Mechanical
Engineering and an MBA from the University of Michigan. He currently serves on the Board of Governors (Prior Chairman) of the Heavy
Duty Manufacturer&rsquo;s Association, and also serves on the Board of Directors of the Motor &amp; Equipment Manufacturers Association.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: #FEFEFE">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&ldquo;Both Eric and Tim are proven operational
executives, with strong industry experience and a track record of driving profitable growth and serving our customers, said Interim
CEO David Hess. &ldquo;Eric&rsquo;s strong background in aerospace and defense position him to successfully lead EP&amp;S as we
support our customers in meeting their aggressive ramp-up rates, and drive increased share for Arconic on the new jet engine and
airframe platforms.<FONT STYLE="font-size: 10pt">&nbsp; </FONT>Tim&rsquo;s deep operational and commercial experience in the transportation
markets will be key to realizing valuable synergies in our transportation portfolio &ndash; across both GRP and TCS. With this
change, Arconic brings GRP and TCS under a single executive leader, streamlining our management structure.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&ldquo;We thank Karl for his leadership, passion for excellence
and many significant contributions to Arconic. Under his leadership, EP&amp;S improved operating performance and strengthened customer
relationships in the face of an extraordinary ramp up in next generation engine deliveries. He created a team-oriented culture
where innovation flourished. I wish him the very best in his future endeavors,&rdquo; said Hess.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">Eric Roegner <FONT STYLE="background-color: white">&ndash;
full bio</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="background-color: white">Tim
Myers &ndash; full bio</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>About Arconic </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Arconic (NYSE: ARNC) creates breakthrough products that shape industries.
Working in close partnership with our customers, we solve complex engineering challenges to transform the way we fly, drive, build
and power. Through the ingenuity of our people and cutting-edge advanced manufacturing techniques, we deliver these products at
a quality and efficiency that ensure customer success and shareholder value. For more information: <U>www.arconic.com</U>. Follow
@arconic: <U>Twitter</U>, <U>Instagram</U>, <U>Facebook</U>, <U>LinkedIn</U> and <U>YouTube</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><B>Dissemination of Company Information</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Arconic intends to make future announcements regarding Company developments
and financial performance through its website on&nbsp;<U>www.arconic.com</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 2; Options: NewSection Last; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>tv477513_ex10-1img1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tv477513_ex10-1img1.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ /@!" P$1  (1 0,1 ?_$ *D   (!! ,!
M      @)!@0%!PH  0(# 0 !! ,! 0               08'" (#!00)$
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MDDY)J\:-%P2-)L56CTAA5;>Z5,1[3]I@$.GGRS9;BWE-3<2RK]@[MVK&J=
M9D3D9CH91!?PDY Q.NX<MN)HK6!E%*Y4ERF*MKR$K?6I"]BI%22%C5,P)@'6
M#ASOK5AC9&LGKF6*1&V5$B*X1LL0@,;)!+*=H%<P<\V C^/5[R (E YDC@'!
MR&#TZ8EDR2\XY4(JK4^ I!_U>ILCN%)U!_*+'<C\/X#RI0&U9I0,.N$*V5*!
MLJ620/4VX!N!T&ATTZ0I>_FV3\7";&;KF4X;-^M3N118LL;9/GVT9?Z^DLJ(
M%8U-PHJHZ>)-2FX%1B"K< #N49D#D_4MT Q[E%T4S]+^RR @E3S29,K5V.T#
MT_0R,4ES"IY:^'J6[C:KNWD/&GN2%-7.I%:T@$^FG!5-: F14H=#H8;9J_L)
M4]G<10^6*A'R\/'R;^2BGL/-HHIR$5,PZI&LHQ.HV46;/$45Q_5KIF[%2" \
M /(!$^0V*MQRZN6JN(4\V="!(%)Z'6+N<1\I6+F/"*7.<>#R:&H*DE+H 4EQ
M$MZ0!_I!.A[P0O(=<6423N$#AME_YFV%]>/^'L@^OR_VV]]?YNNSC<_[[02Z
M^^C_ )A$5\X?_(,DTG_V2NT\?TSI">,+:6X.R#I%A//"M[5UWRQ7ZS(RG[;X
M>8+7VQ'K&Q2Z3-6U(*/&*$B!4FY"%4242=B4.WN.'!.I?O.87VGSJIM3C(N5
M*M6PL;=X(,IA&AD>H'@=8HUQYP%QU>> +'R*W<ABV:L4@<5=D.[$ME,S[3H*
M@D@R )$SX3.D8.:>4;:^IXXN%/9GJF3T:U.I5=AM$C5[$>#;LU3JH(/Y-F,4
MWBWDFY33]ULJY324$A3"=%<PE$W=7QCB-54LUM0XIA]XS70F05, G:-=)2_A
M$:T/S%YNLV)U5CIJ=-W8I*I5.W?$H66PC=L#QDF2M#,$CN(/+433'"&4C1^R
M66\MM-QLD3!FSLTY)R!W],JLAP18L:WJSE3[@KN/4 "E3?I($3X^AJGU'N59
MG>;9NL-JIS;;:DE,@@!1ET.X#\S/\8LYP?P'@^6);Y*S:](S7*7_ -0%Q>]F
ME*M2CVMQ^W_<!+LF"+V.\>N%\[+$N-=3>8:S!&F*XALFXY!.#?$?MBE!DM.1
MK S5K*$1,0I04**+LA0X*KQZ=<'',[O%G<337(HN%L)]3;G10[IW&9&GUB3^
M4OC#Q]R Z+S94&QYPT &:VW'V3,?:AU*=J5(W2)TG,#7M ,2NPOD:U]N%?U-
MG8_'.7,G9(1%#"N5Y!X""CR(9J."2,C869C,V[MW&-T!,(O2)J$,7D1= (<O
MW_QWC[(J1W,Z8NT5JIW/UZ5 W!)4!MV*)U!()\HKA6\J?*#BZ^4'!U<;?=\P
MO#9_M=R<F"VV@J#BJA$I.JDD2!U$M9SC-]3\=#5TSL^;-OK[)[%9B3K$\_09
M2SA?_0-2=)Q#MPDSB(0Y422(,%BA[8G20:E$H"5N _5TWJS/A2/M6O%Z=-#;
M/W")K3JXYJ$A1\-.T_.)"MGQ:%315^?<VW*IR/-3;7W$MK4I-.P5-*5L::G*
M0.HT F!UB9^'DW=IC$#_ -DY%_S5#K'EKWQEGMU*MSZ:5H*/B9*/\B([_P %
M6D,\%MH;&UL76MDGKM&YL!/X0TS^_J,8N%_G&&L_5&9OV$\N4FN)MU9^X8[M
MU=A473@C5NI)RT*Z9LB.'*A3$02.X4* G$!*4!Y'TZ]]EJD4=RIJQT>AEU*B
M/&2@=/RAD\EV*MRCCZ[6"V@*K:ZW5+#8.@WNH(3N/83T)[3C6?P/2J>ED.L:
M_P#D3N^4<;5['($9XQQ;82K5S%TN*KM9RY6DK2P<&;"@]>+B8CE,OMN"F[1>
ME#A/JQ]_K*MZG5D_'5.P]7NH)?6F16TGNI*2)[DIF1+H1TF8^2O%^/VFDR=C
MC'Y37"XVNR6DI31VM<T6QQ8(VJ6^D[73,])D*GUE&S76,>8NA\?-:35:C3F^
M-EXTK=K7XR*BUJL\B5T@Y$S<J*S&1;ND Y,LI[GNA]0F'X]5SJKA<WJ]=<^_
M4*N6Z942=X/D/'MI'UNM6)81;\;1CUCH+>UB88"DI:2VII2%:;B=4J"@=222
M.L](U^-E&F'L 9PCC>._(=Y9[ RTPBSL.'<2LU[QCATF543NT),H+KQS4R)R
M@"C$/O44@Y]&H!W=3CC2[A>K3_[_ $S2;&$Z/K 2[/HGL"03/73\8^9W+S&#
M\9Y\EKXNW*N'(2G@:FUV\KJ:)<SZ_?4"I*%>"$S )UET@\\2^2)U5)]EBC=W
M'4OKUDI9%$&-J?,W(8VL_>(%3<IO?=>_E'OB(=YR*.61%.0%9/T+TS;KQXTX
M%UF&/(K[8@J4I*/^H@>/8*EY:^465P/Y7NT%=2X=S];7\9RY:-R'%-*33.[1
M, K,]JE#61,O$B+/L9,Q<UY'] I>+>M'\6^K%Y<LG[)=%XS?,UV\NHBZ;.FI
MU6ZK98I@$H@80$!Y^ =)C%/[/'%Z97N#X=:DD@@Z;I@@]Q_CK'!Y7KZ&Y_+'
MC6[4CZ'+7_;'W4/(<0I"O=4H; $DDF13,C0 QEK:7?\ Q!C,TUB.BMI7-N;+
M,RD:W'X]QN4)<T;(2#1>/#\]E&A';1LLV,OW';(@NY#C@Q"!R8.;BF#W:[[+
MM6;*.T-J0I3CYE]I"I #4S T/2)$YE^1^&8HY6X5CI>OG(=33*IQ1TDE%M2T
ME 4XH^D2*MQ2#NEVB8^-+#&0\&:K5NEY/A0KML<V>V65Q"'=-W3J.8SS\CF/
M0D#-3JH(O_MR 91(#F%,1[3#W (!CR5>Z"_Y:_<+8K=2%*$ _P# G:9>7A'9
M^)_'^2\;\0TUDRUH,WIVK?J5(GJD/E"D@^!$M1!^]H_T],*<61V'^,>3)@;C
MG@>/XO\ 'K%4R) RC9J 4IT2>T8@S+@7$^>ZLXJ.6*7#W"%,DH#4K]N))&+7
M, =KN'EVYDY**=$$ X.BH3GC@W(<AUU;3>[K8JI-=:GUM5"5!6FJ209ZH.B@
M>X.A&D,;.>-L&Y'M/]FS2WL5M" 0G>D%;<Q+<VO[DJ'4$'0ZPK9SXR<U0;Q3
M%6.=NK]6M6IYR9W-TETL[=W"*1#W.Z @7Z9DF)HI\0P H;O;)CQRJW6'U&2$
M<CV5Y(N-9:VEY*G4.3VH4KQ4C;+Q,M=>\5#>^)6>4B%8ACN7W"FXG=>*ET^O
M[EILS/MMO>YN4DF29>D!,](8IKUJ=A'6:")#XKJ#*,>+H E,6I\0LC<)\X$
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MP7QUQ/2)1C5$EVZ$S<K*@!VJ>6>JENJU/E*0'2"I(0" (!^(\_U!_9TW0
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F]B?+2Y;(QR?C_&-I0C&;XYTHP!AFS,8\B0M140[#B006/1!'_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>tv477513_ex99-1img1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tv477513_ex99-1img1.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ 2P#U P$1  (1 0,1 ?_$ +8   $#!0$! 0
M       '"0H" P4&" $+! $!  $$ P$               <%!@@) 0($ Q
M  8! P($ @@$ P4)     0(#! 4&!P 1"!()(3$3%"(R08'!0H(5%@I182,S
M<9$7L7(D&!FAT?%2-#:X.7D1  $# P,"! 0#!@,( P    $  @,1! 4A!@<Q
M$D%1(@AA<8$3,D(4H;'!8B,5D5()\-'A<K(S)!;2<Q?_V@ , P$  A$#$0 _
M )^&B*Z/R?4'V:(@/D^H?MT16M$1HBNG\OK^P=$0/R?4'V:(O2?*'U_[1T15
M:(C1$:(C1$:(C1$:(C1$:(C1$:(C1$:(C1$:(C1$:(C1$:(C1$:(C1%3]_\
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M4C@7^(-O@W\=$6PU.[TN_12<[1;=5[I!K;>C,U.?BK'%*]0"(>G(P[MXT/N
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MI+_'01#./I\G5GE+5AH5-*%:,:R\AU('\IB46":248V:Q2OHMRHE*5 I2]
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$$7__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>tv477513_ex99-2img1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tv477513_ex99-2img1.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ 2P#U P$1  (1 0,1 ?_$ +0   $#! ,!
M       '"0H#!08( 0($"P$!  $$ P$               <%!@@) 0(#!!
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M?,'&G,7'/N#7NZ.LG/+4\A2MU9FCV%B^Q\>"<R#&Z4?^7V2O72B3R$Z1(0<
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M@>E$I&,EUB=50^W5K*S:L=GMV(;:R]]'?W,VC6>6FH'=J0!KK_4M*/-.3O\
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MW$NYUF;%$2VJQI;)3%&(8K.'3N(1=-6::)S+*$#81(K\[YC8!1@*/8&=NF+
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M>"R0D@TJL>Q[W:+QB-&9QSS)P]:8K)%9:K%;2,#'-X9U/NT $J*$Q"2)T&+
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I1HB-$1HB-$1HB-$1HB-$1HB-$1HB-$1HB-$1HB-$1HBZ_G_3^.B+_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
